Hormone replacement therapy and cardioprotection in the elderly

Journal of the Royal Society of Medicine

Volumn 91, Issue 9, 1998, Pages 475-478

  Pines, A ^a,b,d   Kessel, H ^c   Mijatovic, V ^c   Van Der Mooren, M J ^c  

^a TEL AVIV UNIVERSITY   (Israel)

^b Ramat Marpe Hospital   (Israel)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

AGED; CLINICAL TRIAL; CORONARY ARTERY DISEASE; EPIDEMIOLOGY; FOLLOW UP; HEART PROTECTION; HORMONE SUBSTITUTION; HUMAN; META ANALYSIS; MORTALITY; NONHUMAN; POSTMENOPAUSE OSTEOPOROSIS; PRIMARY PREVENTION; SECONDARY PREVENTION; SHORT SURVEY;

EID: 0031657123     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1177/014107689809100906     Document Type: Short Survey

References (33)

1. Rich Edwards JW, Manson JE, Hennekens CH, Buring JE. The primary prevention of coronary heart disease in women. N Engl J Med 1995;332:1758-66
2. Grodstein F, Stampfer MJ, Manson JE, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996;335:453-61
3. Collins P, Rosano GMC, Sarrel PM, et al. 17β estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation 1995;92:24-30
4. Kawano H, Motoyama T, Kugiyama K, et al. Gender difference in improvement of endothelial-dependent vasodilation after estrogen supplementation. J Am Coll Cardiol 1997;30:914-19
5. Samaan SA, Crawford MH. Estrogen and cardiovascular function after menopause. J Am Coll Cardiol 1995;26:1403-10
6. Mijatovic V, Pines A, Stehouwer CDA, van der Mooren MJ, Kenemans P. The effects of oestrogen on vessel wall and cardiac function, haemostasis and homocysteine metabolism. Eur Menopause J 1996;3:209-18
7. Pines A, Mijatovic V, van der Mooren MJ, Kenemans P. Hormone replacement therapy and cardioprotection: basic concepts and clinical considerations. Eur J Obstet Gynecol Rep Biol 1997;71:193-7
8. Wren GB. Blood pressure. Effects of estrogen and management of hypertension in women. In: Lobo RA, ed. Treatment of the P Postmenopausal Woman: Basic and Clinical Aspects. New York: Raven, 1994:283-5
9. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 1995;273:199-208
10. Alfie J, Lugones L, Belardo A, et al. Hemodynamic effects of transdermal estradiol alone and combined with norethisterone acetate. Maturitas 1997;27:163-9
11. van der Mooren MJ. Reduced blood pressure in hypertensive women on combined oestradiol/dydrogesterone therapy [Abstract]. Acta Obstet Gynecol Scand 1997;76(suppl 167:5):59
12. European Consensus Development Conference on Menopause. Cardiovascular disease and menopause. Participants: Vessey M, Stampfer M, Breart G, Godsland I, Pines A, Samsioc G, Sullivan J. Hum Reprod 1996;11:975-9
13. American College of Physicians. Guidelines for counselling postmenopausal women about preventive hormone therapy. Ann Intern Med 1992;117:1038-41
14. Mosca L, Manson JE, Sutherland SE, Langer RD, Naolio T, Barrett-Connor E. Cardiovascular disease in women. A statement for healthcare professionals from the American Heart Association. Circulation 1997;96:2468-82
15. Handa VI, Landerman RL, Hanlon JT, Harris T, Cohen HJ. Do older women use estrogen replacement? Data from the Duke Established Populations for Epidemiologic Studies of the Elderly (EPESE). J Am Geriatr Soc 1996;44:1-6
16. Ettinger B, Quesenberry C, Schroeder DA, Friedman G. Long-term postmenopausal estrogen therapy may be associated with increased risk of breast cancer: a cohort study. Menopause 1997;4:125-9
17. Salamone LM, Pressman AR, Seeley DG, Cauley JA. Estrogen replacement therapy. A survey of older women's attitudes. Arch Intern Med 1996;156:1293-7
18. Miller KI. Hormone replacement therapy in the elderly. Clin Obstet Gynecol 1996;39:912-32
19. Ettinger B, Friedman GD, Bush T, Quesenberry CP Jr. Decreased mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol 1996;87:6-12
20. Sidney S, Petitti DB, Quesenberry CP Jr. Myocardial infarction and the use of estrogen and estrogen progestogen in postmenopausal women. Ann Intern Med 1997;127:501-8
21. Psaty BM, Heckbert SR, Atkins D, et al. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women. Arch Intern Med 1994;154:1333-9
22. Henderson BE, Paganini-Hill A, Ross RK. Reduced mortality in users of estrogen replacement therapy. Arch Intern Med 1991;151:75-8
23. Bush TL, Barrett-Connor E, Cowan LD, et al. Cardiovascular mortality and noncontraceptive use of estrogen in women. Results from the Lipid Research Clinics Program Follow Up Study. Circulation 1987;75:1102-9
24. Falkeborne M, Persson I, Adami H-O, Bergstrom R, Eaker E, Lithell H, Mohsen R, Naessen T. The risk of acute myocardial infarction after oestrogen and oestrogen progestogen replacement. Br J Obstet Gynaecol 1992;99:821-8
25. Folsom AR, Mink PJ, Sellers TA, Hong CP, Zheng W, Potter JD. Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. Am J Publ Health 1995; 85:1128-32
26. Manolio TA, Furberg CD, Shemanski U, et al. Association of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. Circulation 1993;88[part 1]:2163-71
27. White MM, Zamudio S, Stevens T, et al. Estrogen, progesterone, and vascular reactivity: potential cellular mechanisms. Endocr Rev 1995;6: 739-51
28. Gruchow HW, Anderson AJ, Barboriak JJ. Sabocinsky KA. P Postmenopausal use of estrogen and occlusion of coronary arteries. Am Heart J 1988;115:954-63
29. Hong MK, Romm PA, Reagen K, Green CE, Rackley CE. Effects of e estrogen replacement therapy on serum lipid values and a angiographically defined coronary artery disease in postmenopausal w women. Am J Cardiol 1992;69:176-8
30. Newton KM, LaCroix AZ, McKnight B, et al. Estrogen replacement t therapy and prognosis after first myocardial infraction. Am J Epidemiol 1997;145:.269-77
31. Sullivan J, Vander Zwaag R, Hughes JP, et al. Estrogen replacement and coronary artery disease: effect on survival in postmenopausal women. Arch Intern Med 1990;150:2557-62
32. Sullivan JM, El-Zeky F, Vander Zwaag R, Ramanathan KB. Effect on s survival of estrogen replacement therapy after coronary artery bypass g grafting. Am J Cardiol 1997;79:847-50
33. O'Keefe JH, Kim SC, Hall RR, Cochran VC, Lawhorn SL, McCallister BD. Estrogen replacement therapy after coronary angioplasty in women. J Am Coll Cardiol 1997;29:1-5